🎉 M&A multiples are live!
Check it out!

Granules India Valuation Multiples

Discover revenue and EBITDA valuation multiples for Granules India and similar public comparables like Vivoryon Therapeutics, Galapagos, and Julphar.

Granules India Overview

About Granules India

Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World. The company generates a majority of its revenue from its business outside India.


Founded

1991

HQ

India
Employees

4.1K+

Financials

LTM Revenue $521M

LTM EBITDA $113M

EV

$1.4B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Granules India Financials

Granules India has a last 12-month revenue of $521M and a last 12-month EBITDA of $113M.

In the most recent fiscal year, Granules India achieved revenue of $522M and an EBITDA of $96.0M.

Granules India expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Granules India valuation multiples based on analyst estimates

Granules India P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $522M $522M XXX XXX XXX
Gross Profit $205M $245M XXX XXX XXX
Gross Margin 39% 47% XXX XXX XXX
EBITDA $105M $96.0M XXX XXX XXX
EBITDA Margin 20% 18% XXX XXX XXX
Net Profit $47.9M $60.0M XXX XXX XXX
Net Margin 9% 12% XXX XXX XXX
Net Debt $105M $89.1M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Granules India Stock Performance

As of April 15, 2025, Granules India's stock price is INR 452 (or $5).

Granules India has current market cap of INR 110B (or $1.3B), and EV of INR 118B (or $1.4B).

See Granules India trading valuation data

Granules India Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.4B $1.3B XXX XXX XXX XXX $0.24

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Granules India Valuation Multiples

As of April 15, 2025, Granules India has market cap of $1.3B and EV of $1.4B.

Granules India's trades at 2.6x LTM EV/Revenue multiple, and 12.2x LTM EBITDA.

Analysts estimate Granules India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Granules India and 10K+ public comps

Granules India Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.4B XXX XXX XXX
EV/Revenue 2.7x XXX XXX XXX
EV/EBITDA 12.8x XXX XXX XXX
P/E 23.4x XXX XXX XXX
P/E/Growth 0.9x XXX XXX XXX
EV/FCF 73.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Granules India Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Granules India Valuation Multiples

Granules India's NTM/LTM revenue growth is 15%

Granules India's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $48K for the same period.

Over next 12 months, Granules India's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Granules India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Granules India and other 10K+ public comps

Granules India Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 0% XXX XXX XXX XXX
EBITDA Margin 21% XXX XXX XXX XXX
EBITDA Growth -9% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 36% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $48K XXX XXX XXX XXX
S&M Expenses to Revenue 6% XXX XXX XXX XXX
G&A Expenses to Revenue 2% XXX XXX XXX XXX
R&D Expenses to Revenue 4% XXX XXX XXX XXX
Opex to Revenue 38% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Granules India Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Granules India M&A and Investment Activity

Granules India acquired  XXX companies to date.

Last acquisition by Granules India was  XXXXXXXX, XXXXX XXXXX XXXXXX . Granules India acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Granules India

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Granules India

When was Granules India founded? Granules India was founded in 1991.
Where is Granules India headquartered? Granules India is headquartered in India.
How many employees does Granules India have? As of today, Granules India has 4.1K+ employees.
Who is the CEO of Granules India? Granules India's CEO is Dr. Kandiraju Venkata Sitaramrao.
Is Granules India publicy listed? Yes, Granules India is a public company listed on BOM.
What is the stock symbol of Granules India? Granules India trades under 532482 ticker.
When did Granules India go public? Granules India went public in 2002.
Who are competitors of Granules India? Similar companies to Granules India include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Granules India? Granules India's current market cap is $1.3B
What is the current revenue of Granules India? Granules India's last 12-month revenue is $521M.
What is the current EBITDA of Granules India? Granules India's last 12-month EBITDA is $113M.
What is the current EV/Revenue multiple of Granules India? Current revenue multiple of Granules India is 2.6x.
What is the current EV/EBITDA multiple of Granules India? Current EBITDA multiple of Granules India is 12.2x.
What is the current revenue growth of Granules India? Granules India revenue growth between 2023 and 2024 was 0%.
Is Granules India profitable? Yes, Granules India is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.